ATE138574T1 - Verwendung von prostaglandin f3alpha als okulares hypotensivum - Google Patents

Verwendung von prostaglandin f3alpha als okulares hypotensivum

Info

Publication number
ATE138574T1
ATE138574T1 AT91905633T AT91905633T ATE138574T1 AT E138574 T1 ATE138574 T1 AT E138574T1 AT 91905633 T AT91905633 T AT 91905633T AT 91905633 T AT91905633 T AT 91905633T AT E138574 T1 ATE138574 T1 AT E138574T1
Authority
AT
Austria
Prior art keywords
prostaglandin
f3alpha
occular
hypotensive
reducing
Prior art date
Application number
AT91905633T
Other languages
English (en)
Inventor
David Frederick Woodward
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of ATE138574T1 publication Critical patent/ATE138574T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT91905633T 1990-03-12 1991-02-12 Verwendung von prostaglandin f3alpha als okulares hypotensivum ATE138574T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/491,546 US5011856A (en) 1990-03-12 1990-03-12 Use of prostaglandin F3 α as an ocular hypotensive agent

Publications (1)

Publication Number Publication Date
ATE138574T1 true ATE138574T1 (de) 1996-06-15

Family

ID=23952683

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91905633T ATE138574T1 (de) 1990-03-12 1991-02-12 Verwendung von prostaglandin f3alpha als okulares hypotensivum

Country Status (11)

Country Link
US (1) US5011856A (de)
EP (1) EP0527748B1 (de)
JP (1) JPH05504962A (de)
AT (1) ATE138574T1 (de)
CA (1) CA2075951A1 (de)
DE (1) DE69119900T2 (de)
ES (1) ES2088489T3 (de)
FI (1) FI924088A0 (de)
HU (1) HUT61470A (de)
IE (1) IE910794A1 (de)
WO (1) WO1991013620A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270049A (en) * 1990-11-09 1993-12-14 Allergan, Inc. 2-decarboxyl-2-aminoalkyl-prostaglandins as ocular hypotensives
US5139491A (en) * 1990-12-06 1992-08-18 Allergan, Inc. 2-decarboxyl-2-alkoxyalkyl prostaglandins as ocular hypotensives

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4055593A (en) * 1971-02-19 1977-10-25 Alza Corporation Alkyl diethers of prostaglandins
US3940438A (en) * 1971-05-24 1976-02-24 Alza Corporation Crystalline racemic 9α,11α,15(S)-trihydroxy-5-cis,13-trans-prostadienoic acid
US3853854A (en) * 1971-06-24 1974-12-10 Alza Corp Novel 5{40 ,6{40 -dihydro-2h-pyran-4{40 -yl prostaglandin ethers
US4001306A (en) * 1971-12-30 1977-01-04 The Upjohn Company Prostaglandin F.sub.α 15-monoacrylates
US3882245A (en) * 1972-11-01 1975-05-06 Upjohn Co Use of prostaglandins in combating shock
US3941886A (en) * 1973-09-21 1976-03-02 Alza Corporation Pharmaceutical compositions containing crystalline racemic 9α, 11α, 15(S)-trihydroxy-5-cis, 13-trans-prostadienoic acid
US4049678A (en) * 1976-03-29 1977-09-20 The Upjohn Company 9-Deoxy-PGD-type, 1,15-lactones
US4201873A (en) * 1975-09-17 1980-05-06 The Upjohn Company 9-Deoxy-9,10-didehydro-PGD2 analogs
US4016184A (en) * 1975-09-17 1977-04-05 The Upjohn Company 9-Deoxy-9,10-didehydro-PGD1 compounds
US4033989A (en) * 1975-09-17 1977-07-05 The Upjohn Company 9-Deoxy-PGF2 Analogs
US4060540A (en) * 1975-09-18 1977-11-29 American Cyanamid Company Novel 3-triphenylmethoxy-1-alkynes, 3-triphenyl-methoxy-1-trans-alkenyl-dialkyl-alanes, and lithium 3-triphenylmethoxy-1-trans-alkenyl-dialkyl alanates
US4149007A (en) * 1977-06-23 1979-04-10 Miles Laboratories, Inc. C14 Phenyl-substituted derivatives of prostaglandin analogues
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
US4883819A (en) * 1986-07-31 1989-11-28 The Trustees Of Columbia University In The City Of New York Use of A, B and C prostaglandins and derivatives thereof to treat ocular hypertension and glaucoma
US4824857A (en) * 1986-05-16 1989-04-25 Yasumasa Goh Use of prostaglandin D2 -active substances
US4822819A (en) * 1986-11-07 1989-04-18 Alcon Laboratories, Inc. Use of trimoprostil and derivatives in glaucoma therapy
ZA88963B (en) * 1987-02-27 1989-11-29 Allergan Inc Prostaglandins useful for lowering intraocular pressure
ATE76750T1 (de) * 1987-04-03 1992-06-15 Univ Columbia Anwendung eines prostaglandins in mischung mit einem adrenergischen blocker zur verminderung des augen-innendruckes.
SE8703854D0 (sv) * 1987-10-07 1987-10-07 Pharmacia Ab Prostaglandinderivat for behandling av glaukom eller okuler hypertension
AU654167B2 (en) * 1990-12-10 1994-10-27 Allergan, Inc. Homo-prostaglandin derivatives as ocular hypotensives

Also Published As

Publication number Publication date
DE69119900T2 (de) 1997-02-06
HUT61470A (en) 1993-01-28
FI924088A7 (fi) 1992-09-11
US5011856A (en) 1991-04-30
EP0527748B1 (de) 1996-05-29
CA2075951A1 (en) 1991-09-13
JPH05504962A (ja) 1993-07-29
EP0527748A4 (en) 1993-03-10
EP0527748A1 (de) 1993-02-24
FI924088L (fi) 1992-09-11
WO1991013620A1 (en) 1991-09-19
IE910794A1 (en) 1991-09-25
FI924088A0 (fi) 1992-09-11
ES2088489T3 (es) 1996-08-16
DE69119900D1 (de) 1996-07-04

Similar Documents

Publication Publication Date Title
YU47204B (sh) Derivati didehidro-vitamina d3
NL300389I1 (nl) Thiofeensulfonamiden die bruikbaar zijn als carbo-anhydraseremmers.
YU48666B (sh) Mometason furoat monohidrat i postupak za njegovo dobijanje
SE8503680D0 (sv) Indolderivat
MX9805020A (es) Analogos de prostaglandinas de tetrahidrofurano substituido como hipotensores oculares.
DK0646008T3 (da) Minimering af gennemblødning i forbindelse med progestin
ATE250625T1 (de) IM WESENTLICHEN REINES ZONULIN ALS PHYSIOLOGISCHER MODULATOR VON ßTIGHT JUNCTIONSß BEI SÄUGERN
MY106109A (en) 3-arylcarbonyl-1-aminoalkyl-1h-indole-containing antiglaucoma compositions
ES2166470T3 (es) Derivados de indolalquilo de la benzodioxanmetilamina como ligandos de los receptores 5-ht1a.
CO4230097A1 (es) Piridopirimidinas sustituidas como antihipertensivos
ES2046500T3 (es) Derivado de la histamina, su preparacion y su aplicacion en terapeutica.
UA42819C2 (uk) Ін`єкційний та інфузійний розчин, що містить енрофлокcацин
AU5355498A (en) 15-fluoro prostaglandins as ocular hypotensives
PT684816E (pt) Composicoes antagonistas do receptor da 5-ht2 uteis no tratamento de doencas venosas
DK0638068T3 (da) Fremgangsmåde til fremstilling af (S)-3-amino-1-substitueret-pyrrolidiner
DE3769691D1 (de) Substituierte oximether, ihre verwendung als bioregulatoren zur senkung des endogenen ethylenspiegels in pflanzen.
ES2157899T3 (es) Derivados de sampangina utiles como agentes antifungicos y antimicobacterianos.
ES2174113T3 (es) Nuevos derivados de ((3-alcoxi-fenoxi)-etil)-dialquilamina y su utilizacion como anestesicos locales.
ES2175437T3 (es) Composicion de enalapril y losartan.
BG44379A3 (en) Method for preparing of 9- chlor- 1, 5- benzothiazepine derivatives
ES2079872T3 (es) Derivados hipotensores oculares de la 2-descarboxil-2-aciltioalquilprostaglandina.
DE69119900D1 (de) Verwendung von Prostaglandin F3alpha als okulares Hypotensivum
ES2162078T3 (es) Compuestos terapeuticos.
ES2060944T3 (es) Derivados de 2,5,6,7-tetranor-4,8-inter-m-fenileno de pgi2 (prostaglandina i2).
ATE22531T1 (de) Pharmazeutische zusammenstellung fuer induktion von cytoprotektion.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties